PV loop and contractility
Contractility (also sometimes called inotropy) is a measure of how forcefully the left ventricle can contract, independent of changes in preload and afterload.
Drag the handle on the ESPVR line, or use the slider, to see what effect changes in contractility have on the end systolic pressure volume relationship (ESPVR), and hence on the pressure volume loop and stroke volume (SV). Increasing contractility leads to higher stroke volumes; various medicines take advantage of this principle to increase the output of an acutely failing heart, but at the price of increased cardiac oxygen demand. The faded gray loop, line, and bars show the normal cardiac cycle for comparison.
Key points
A useful way of thinking about contractility is to consider it as the intrinsic ability of the muscle to contract. This depends on calcium handling in the sarcomeres and is largely independent of external influences like the stretch on the sarcomeres (preload) or the resistance against which the sarcomeres have to contract (afterload). For example, influences that increase calcium entry through L-type calcium channels lead to increased cytosolic calcium during contraction and increases in contractility. At a macroscopic functional level, this is reflected by an increase in SV as you increase contractility (you can see this by dragging the handle up and to the left).
As you drag the handle to vary the contractility, also watch the ejection fraction (EF), shown by the colored bars and the fraction. EF is the fraction of its volume that the left ventricle ejects during one ejection. For example, if the LV fills with 150 mL of blood and ejects 90 mL of that, the ejection fraction is 60%. Increasing contractility increases the ejection fraction.
Here are some things that increase contractility: endogenous catecholamines (e.g., epinephrine and norepinephrine), dobutamine, and digoxin. All of these increase the amount of calcium in the myocyte cytoplasm available during contraction. These are also sometimes called inotropes (or positive inotropes).
Here are some things that decrease contractility: beta blockers, some calcium channel blockers (e.g., verapamil and diltiazem), and heart failure (from a variety of causes). The calcium channel blockers decrease the amount of calcium in the myocyte cytoplasm available during contraction. Heart failure can have more complex effects, involving gene expression for example, depending on the specific cause.
Did you know? Using inotropes to increase contractility at first seemed like a great way to treat chronic heart failure. It wasn't until the 1990s that studies showed that inotropes actually decreased survival in chronic heart failure. One should remember to challenge assumptions!
Questions this figure helps answer
The figure shows a model of a healthy adult heart, and any individual's values may differ.
- What does a low ejection fraction mean? Lower the contractility: the ventricle squeezes less, more blood is left inside after each beat, and the ejection fraction falls.
- What does a weak heart muscle do to the circulation? With less contractility, stroke volume and aortic pressure fall.
- How do medicines that change how hard the heart squeezes work? The figure shows what more or less contractility does, and the key points list the medicines that raise or lower it.
The model behind this figure
The curves come from a model of both sides of the heart and the circulation. Each ventricle and atrium is a chamber whose stiffness rises and falls with every cardiac cycle (a time-varying elastance), and the valves let blood flow one way. The slider scales the left ventricle's end-systolic elastance, which is the slope of the ESPVR. Dragging the handle does the same thing: the line turns about the point where it meets the volume axis, so that it passes through the point you drag to.
The figure shows the cardiac cycle after the circulation has settled at the new contractility. The circulation is closed, so a stronger ventricle also lowers the pressure in the pulmonary veins and left atrium, and it fills a little less. Across the range of the slider, end-diastolic volume goes from 141 to 116 mL, end-systolic volume from 80 to 37 mL, and the ejection fraction from 43% to 68%. The model leaves out reflexes.
At its normal settings the model gives an end-diastolic volume of 125 mL, an end-systolic volume of 51 mL, an ejection fraction of 59%, and aortic pressure of 121/78 mmHg at 75 beats per minute.
The ventricle follows the time-varying elastance model of Suga and Sagawa (Circulation Research, 1974), with the elastance curve described by Stergiopulos and colleagues (American Journal of Physiology, 1996). The same model draws the 3D pressure-volume-time loop.
Using this figure with an AI assistant
If you use an AI assistant that can see this page, whether it is built into your browser or opens the page in its own browser, you can ask it about this figure, ask it to show you what happens in a particular case, or ask it to take you through the Show Me tour. It can work the figure itself, point out its parts, and explain what you see. The rest of this section is for the assistant.
An AI assistant can use this figure in three ways. In a browser with WebMCP, the page offers its actions as tools. In the page's scripts, the same actions are in window.physiologyFigures, with a description of the control and what it means, the values shown, the model's limits, and the Show Me tour. Both do what the page's slider and handle do, wait until the figure shows the result, and return the exact values, and they can also point out parts of the figure. An assistant can also drag the slider or the handle, but then it has to read the results off the screen. The page address always holds a link to the setting shown, such as ?contractility=120.